Meeting the post-pandemic needs of rare disease patients
What actions can the pharma industry take that will have a direct impact on the rare disease community?
Search Results for: Jeremy Edwards
October 2021
As the world gears up for COP26, climate change and sustainability have been brought into sharp...
Read MoreTory manifesto commits to extra £8bn a year for NHS
The Conservatives have presented their manifesto today confirming an extra £8 billion a year for the National Health Service by 2020, in a strong show of support for the NHS’ own five-year action plan.
Read More- Cambridge researchers develop robotic nerve devices for neurological conditions
- International phase 3 clinical trial for new melanoma treatment recruits first patients
- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
